Metformin attenuates vascular pathology by increasing expression of insulin-degrading enzyme in a mixed model of cerebral amyloid angiopathy and type 2 diabetes mellitus
Yasuteru Inoue, Teruaki Masuda, Yohei Misumi, Yukio Ando, Mitsuharu Ueda
Topics & Concepts
MetforminCerebral amyloid angiopathyInsulin-degrading enzymeMedicineInternal medicineEndocrinologyType 2 Diabetes MellitusDiabetes mellitusNeprilysinHippocampusAmyloid precursor proteinAmyloid precursor protein secretaseInsulinAlzheimer's diseasePharmacologyDementiaEnzymeChemistryDiseaseBiochemistryAlzheimer's disease research and treatmentsMetabolism, Diabetes, and CancerParkinson's Disease Mechanisms and Treatments